Tumor Prevention and Genetics III 1st Editon 2004 Hardbound at Meripustak

Tumor Prevention and Genetics III 1st Editon 2004 Hardbound

Books from same Author: H.-J. Senn, R. Morant

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 34275/- [ 5.00% off ]

    Seller Price: ₹ 32561

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock
General Information  
Author(s)H.-J. Senn, R. Morant
PublisherSpringer
Edition1st Edition
ISBN9783540222286
Pages334
BindingHardbound
LanguageEnglish
Publish YearDecember 2004

Description

Springer Tumor Prevention and Genetics III 1st Editon 2004 Hardbound by H.-J. Senn, R. Morant

Lifestyle and Medical Approaches to Cancer Prevention.- Application of Genetics to the Prevention of Colorectal Cancer.- Genetics and Prevention of Oesophageal Adenocarcinoma.- Preclinical Models Relevant to Diet, Exercise, and Cancer Risk.- Individualizing Interventions for Cancer Prevention.- Can Animal Models Help Us Select Specific Compounds for Cancer Prevention Trials?.- Problems with Using Biomarkers as Surrogate End Points for Cancer: A Cautionary Tale.- Can a Marker Be a Surrogate for Development of Cancer, and Would We Know It if It Exists?.- How Should We Move the Field of Chemopreventive Agent Development Forward in a Productive Manner?.- The Problems with Risk Selection; Scientific and Psychosocial Aspects.- Chemoprevention of Lung Cancer.- Anti-nicotine Vaccination: Where Are We?.- Primary Prevention of Colorectal Cancer: Lifestyle, Nutrition, Exercise.- Chemoprevention of Colorectal Cancer: Ready for Routine Use?.- Screening of Colorectal Cancer: Progress and Problems.- The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence.- Innovative Agents in Cancer Prevention.- The IARC Commitment to Cancer Prevention: The Example of Papillomavirus and Cervical Cancer.- Health Economics in the Genomic Age.- Screening for Cancer: Are Resources Being Used Wisely?.